European Society of Gynaecological Oncology/European Network of Gynaecological Advocacy Groups Position on risk-based cervical cancer screening

The Risk-Based Screening for Cervical Cancer project was a 4-year Horizon 2020 European research consortium that developed and validated a risk stratified approach to cervical cancer screening, moving away from the current one-size-fits-all model. The European Society of Gynecological Oncolog and its network, the European Network of Gynecological Advocacy Groups, participated as partners, contributing their expertise from both professiona medical society and patient advocacy perspectives. The project’s key findings support replacing cytology with human papillomavirus (HPV) deoxyribonucleic acid testing as the primary screening modality, as it provides greater protection against invasive cervical cancer. Gender-neutral HPV vaccination is endorsed as a strategy to accelerate herd immunity, p